Effect of hCG or hCG+ treatments in young thalassemic patients with hypogonadotropic hypogonadism

Journal of Endocrinological Investigation
R BalducciB Boscherini

Abstract

Hypogonadotropic hypogonadism (HH) is common (40%) in beta-thalassemic patients. Taking into consideration that in HH non-thalassemic patients we obtained good results in pubertal development using hCG treatment (1500 IU every 6 days), 10 HH thalassemic subjects (14 5/12 -17 yr, all with bone age greater than 13 6/12) were treated with the same regimen. In 5 of these patients purified FSH (75 IU every 3 days) was added to hCG in order to evaluate the FSH effect on testosterone (T) response (Group 1 was given hCG alone, Group 2 hCG + FSH: Profasi HP and Metrodin Serono). To evaluate the kinetics of testosterone response, plasma level of T was determined basally and 1, 2, 4 and 6 days after hCG injection. This dynamic study and a clinical examination were carried out at the beginning of treatment and at the 4th and 12th month after. Results obtained in the first group confirmed our previous data from non-thalassemic HH patients: in fact, after 12 months of therapy a stage G2-G3 was reached. In the second group, however, testis size and testosterone secretion were significantly higher than in the first group.(ABSTRACT TRUNCATED AT 250 WORDS)

References

Aug 1, 1978·Clinical Endocrinology·H LandauE A Rachmilewitz
Jun 1, 1979·The Journal of Clinical Endocrinology and Metabolism·O A KletzkyD R Mishell
May 1, 1979·American Journal of Diseases of Children·G CostinJ A Ortega
Dec 1, 1977·British Journal of Sports Medicine·R J ShephardT Fried
Jan 1, 1977·Acta paediatrica Scandinavica·C AnoussakisG Bechrakis
Nov 1, 1976·Archives of Disease in Childhood·D M FlynnB E Clayton
May 1, 1987·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R BalducciB Boscherini
Jan 1, 1985·The Journal of Pediatrics·C Borgna-PignattiV Gabutti
Jun 1, 1968·The Journal of Clinical Endocrinology and Metabolism·B KuoM S Roginsky
Jan 1, 1974·Annals of the New York Academy of Sciences·M N LassmanM Genel
Jan 1, 1974·Annals of the New York Academy of Sciences·V C CanaleM Erlandson
Feb 1, 1970·Archives of Disease in Childhood·W A Marshall, J M Tanner
Apr 1, 1984·Clinical Endocrinology·D P LivadasD A Koutras
Nov 1, 1984·The Journal of Clinical Endocrinology and Metabolism·A M MatsumotoW J Bremner
Aug 1, 1983·The Journal of Clinical Endocrinology and Metabolism·V ToscanoB Boscherini
Dec 1, 1980·Metabolism: Clinical and Experimental·J D Wilson, J E Griffin
Sep 4, 1981·Deutsche medizinische Wochenschrift·E Nieschlag

❮ Previous
Next ❯

Citations

Mar 1, 1992·Journal of Endocrinological Investigation·L DanesiE E Polli
Jun 11, 2009·Journal of Endocrinological Investigation·G BalerciaG P Littarru

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.